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Genomic exploration of sequential clinical
isolates reveals a distinctive molecular
signature of persistent Staphylococcus
aureus bacteraemia
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Mark Schultz4, Ruth C. Massey6, Natasha E. Holmes2, Timothy P. Stinear1 and Benjamin P. Howden1,2,4*
Abstract
Background: Large-scale genomic studies of within-host diversity in Staphylococcus aureus bacteraemia (SAB) are
needed to understanding bacterial adaptation underlying persistence and thus refining the role of genomics in
management of SAB. However, available comparative genomic studies of sequential SAB isolates have tended to
focus on selected cases of unusually prolonged bacteraemia, where secondary antimicrobial resistance has
developed.
Methods: To understand bacterial genetic diversity during SAB more broadly, we applied whole genome
sequencing to a large collection of sequential isolates obtained from patients with persistent or relapsing
bacteraemia. After excluding genetically unrelated isolates, we performed an in-depth genomic analysis of
point mutations and chromosome structural variants arising within individual SAB episodes.
Results: We show that, while adaptation pathways are heterogenous and episode-specific, isolates from persistent
bacteraemia have a distinctive molecular signature, characterised by a low mutation frequency and high proportion
of non-silent mutations. Analysis of structural genomic variants revealed that these often overlooked genetic events
are commonly acquired during SAB. We discovered that IS256 insertion may represent the most effective driver of
within-host microevolution in selected lineages, with up to three new insertion events per isolate even in the absence
of other mutations. Genetic mechanisms resulting in significant phenotypic changes, such as increases in vancomycin
resistance, development of small colony phenotypes, and decreases in cytotoxicity, included mutations in key genes
(rpoB, stp, agrA) and an IS256 insertion upstream of the walKR operon.
Conclusions: This study provides for the first time a large-scale analysis of within-host genomic changes during
invasive S. aureus infection and describes specific patterns of adaptation that will be informative for both
understanding S. aureus pathoadaptation and utilising genomics for management of complicated S. aureus
infections.
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Background
The outcome of Staphylococcus aureus bacteraemia
(SAB) is a result of a complex interaction of host, patho-
gen, and treatment factors. Persistence, usually defined
as bacteraemia of greater than 3–7 days duration, is an
important factor in SAB outcome [1], including
secondary antibiotic resistance development, metastatic
infectious complications, and mortality [2]. Persistent
bacteraemia involves a sequence of events, including in-
vasion, immune evasion, and establishment of secondary
infectious foci, usually all in the context of antimicrobial
treatment [3]. From the bacterial perspective, invasive S.
aureus isolates are subjected to the pressures of the im-
mune response, lack of nutrients, and antibiotics. These
environmental challenges constitute a significant select-
ive pressure driving adaptive evolution in the pathogen,
and access to sequential isolates from patients with per-
sistent SAB offers the opportunity to understand pathoa-
daptation during invasive S. aureus infections.
Over the last decade, with increasing availability of
whole-genome sequencing, within-host genomic studies
have addressed S. aureus niches that are important for
pathogenesis [4]. Studies of colonising isolates have un-
covered the “cloud of diversity” of S. aureus colonising
the host and improved our ability to track transmission
networks [5]. Other authors have revealed mutations as-
sociated with the evolution from colonising to invasive
strain in a single patient [6] or in large cohorts [7]. Gen-
omic studies of sequential blood isolates in persistent
SAB have primarily focused on cases with significant
phenotypic changes that might arise in persistent
infection, such as secondary resistance to antibiotics
(especially the vancomycin intermediate phenotype [8,
9], daptomycin resistance [10]), development of the
small-colony phenotype [11, 12], or genetic changes as-
sociated with extreme cases of persistence [13]. How-
ever, these analyses were restricted to a small number of
selected cases and thus offer only limited insights on the
general pattern of S. aureus evolution during SAB. Un-
derstanding the typical pattern of within-host evolution
during SAB through large-scale investigation of paired iso-
lates will potentially identify shared genomic signatures
associated with S. aureus adaptation in vivo and inform
the use of whole-genome sequencing in the management
of SAB more broadly. For example, genomic monitoring
of SAB could be used to distinguish true relapses from
reinfection with a closely related strain, or track mutations
associated with persistence or resistance early in the
course of the disease, an approach that has been recently
demonstrated for lung cancer [14].
To explore genetic changes associated with persistent
or relapsing SAB and compare them to those occurring
between colonising and invasive isolates, we applied bac-
terial whole-genome sequencing to a large cohort of
SAB, regardless of phenotypic changes. In addition to
the commonly investigated mutational variants, we per-
formed a detailed analysis of chromosome structural var-
iants (e.g. large deletions and insertions, insertions of
mobile genetic elements) within same-patient strains.
This explorative approach uncovered a diverse muta-
tional landscape and a molecular signature distinctive of
persistent bacteraemia. Furthermore, we demonstrate for
the first time that structural variation represents an im-
portant mechanism promoting genetic plasticity within
the host, even in the absence of point mutations and in-
sertions and deletions.
Methods
Case and isolate selection
Isolates included in this study were selected from two
multicenter cohorts of SAB (Fig. 1a). The vancomycin
substudy of the Australian and New Zealand Coopera-
tive on Outcome in Staphylococcal Sepsis (ANZCOSS)
study was a retrospective study of S. aureus isolates col-
lected between 2007 and 2008 [15–19]. The Vancomycin
Efficacy in Staphylococcal Sepsis in Australasia (VA-
NESSA) cohort was a prospective, multicentre study that
has been designed to establish the impact of host, patho-
gen, and antimicrobial factors on outcome from SAB
and has recruited patients between 2012 and 2013 [20].
Both studies collected data on patient demographics,
comorbidities, clinical characteristics, duration of
bacteraemia, 30-day mortality, and SAB recurrence.
Antistaphylooccal treatment of the index SAB episode
was also recorded and is listed in Additional file 1:
Table S1. Overall, methicillin-resistant S. aureus
(MRSA) bacteraemia was treated with vancomycin,
and methicillin-susceptible S. aureus (MSSA) bacter-
aemia was treated with flucloxacillin or cefazolin
(vancomycin was rarely used if there was a contra-
indication to beta-lactams). Median duration of treat-
ment was 26 days (IQR 14–48). Isolates from
subsequent positive blood cultures and from nasal
colonisation screening were available for a subset of
SAB episodes. Therefore, SAB episodes with at least
two blood isolates collected at a minimum of 3 days
apart were included as invasive episodes, and the
isolate collected at the detection of bacteraemia was
defined as index isolate; blood isolates collected sub-
sequently were defined as paired invasive. Episodes
for which colonising S. aureus isolates were available
were included as colonising-invasive pairs (index
isolate: first detected blood isolate; paired colonising
isolate). Invasive isolates collected after the index iso-
late were classified according to the clinical context
in (i) persistent bacteraemia (no negative blood cul-
tures before the collection of the paired isolate); (ii)
relapse on treatment (at least one negative blood
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culture between the index isolate and the paired iso-
late and collection before the end of antistaphylococ-
cal treatment of the index episode); (iii) relapse after
treatment (collection after the end of antistaphylococ-
cal treatment of the index episode).
The first blood culture isolate from each episode
(index isolate), isolates from blood cultures collected at
least 3 days after the index (paired isolates) and colonis-
ing isolates were stored at − 80 °C. Phenotypic confirm-
ation of S. aureus was performed using the coagulase
and DNase tests.
Whole genome sequencing
Bacterial isolates stored in glycerol broth at − 80 °C were
subcultured twice onto horse blood agar. Genomic DNA
was extracted from single colonies using the Janus® auto-
mated workstation (PerkinElmer) or manually using
Invitrogen PureLink genomic DNA kit or the Sigma
GenElute kit. DNA concentration was measured using
the Qubit® dsDNA HS Assay Kit (Life Technologies) and
normalised to a concentration of 0.2 ng/μl for library
preparation with Nextera® XT DNA (Illumina). Genome
sequencing was carried out on the MiSeq® and NextSeq®
(Illumina) platforms with a read length of 2 × 150 bp or
2 × 250 bp (Fig. 1b). The quality of sequencing was eval-
uated by calculating mean read depth (based on a gen-
ome length of 3 million bp), and assessing assembly
metrics obtained using SPAdes, version 3.9.0 [21]. Qual-
ity metrics are listed in Additional file 1: Table S1. Spe-
cies was confirmed by k-mer classification using Kraken,
version 0.10.5-beta [22].
Multi-locus sequence typing and resistome
De novo assemblies of the isolates were generated with
SPAdes [21]. Assembled genomes were scanned for MLST
typing using MLST, version 2.7 (T. Seemann, https://
github.com/tseemann/mlst). Resistance genes were de-
tected from assemblies using Abricate, version 0.3 (T. See-
mann, https://github.com/tseemann/abricate) using the
ResFinder database [23]. Clonal complexes were inferred
using eBurst, version 3 [24].
Global core genome alignment
To obtain a global alignment of all isolates included in
the study (both invasive and colonising), sequence reads
were mapped to S. aureus TW20, a clonal complex (CC)
8/sequence type (ST) 239 methicillin-resistant S. aureus
(MRSA) reference genome (Fig. 1b). [25]. Read mapping,
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Fig. 1 Overview of the study methods. a Episodes with at least two blood isolates at least 3 days’ apart, and episodes with at least one isolate
from a nasal swab were selected from a combined cohort of S. aureus bacteraemia. b DNA was extracted from one single colony. Reads from
whole genome sequencing were mapped to the reference genome S. aureus TW20. Unrelated same-patient isolates (based on clustering on the
phylogenetic tree, MLST, and SNP distance) were excluded from further analysis. c–f Episode-specific phenotypic and genomic analysis. Phenotypic
tests included oxacillin and vancomycin MIC, measured by E-test, overnight growth curves in HI broth, and cell toxicity assays (c). Variants calling for
SNPs and short indels was performed by mapping on the closest available complete genome and the de novo assembly of the index isolate,
respectively. Variants were filtered based on read depth (≥ 10) and fraction of reference alleles (> 0.5) in the index isolate reads and confirmed by
manual inspection of the alignments (d). To identify regions of genome loss that were unique within episode isolates, we scanned the read alignment
to the complete genome for intervals with at least 400 bp read coverage loss (e). Screening for structural variants was performed by detecting split
reads (along the alignment to the complete genome) that were unique within episode isolates. Structural variants were annotated and confirmed by
blasting split intervals on the assembly graph of the episode isolates
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variant calling, and core genome alignment were
performed using the Snippy pipeline, version 3.0 (T. See-
mann, https://github.com/tseemann/snippy). Maximum
likelihood phylogeny was obtained using IQ-TREE, ver-
sion 1.6 [26, 27]. Branch support was calculated using
both ultrafast bootstrap support [28] and the SH-like ap-
proximate likelihood ratio test [29] with threshold values
of 95% and 80%, respectively. The phylogenetic tree was
rooted using Staphylococcus argenteus as an outgroup
[30], and plotted and annotated with the R packages ape
[31] and ggtree [32].
Determination of genetic relatedness of same-patient
isolates
To establish relatedness between same-patient isolates,
we considered tree topology, MLST, and the pairwise
single-nucleotide polymorphism (SNP) distance matrix,
computed from the core genome alignment using the
common reference S. aureus TW20 and from the align-
ment constructed using the de novo assembly of index
isolate. Only related same-patient isolates were kept for
further phenotypic and genomic analysis (episode-speci-
fic analysis).
Episode-specific analysis
Figure 1c–f illustrates phenotypic and genomic analyses
performed on genetically related isolates collected from
the same patient.
Phenotypic testing
Vancomycin and oxacillin minimum inhibitory concen-
tration (MIC) were assessed using Etest (bioMerieux),
according to manufacturer’s instructions. For growth
curves, isolates freshly subcultured were grown over-
night in heart infusion (HI) broth, inoculated into 200 μl
of fresh HI at a 1:400 dilution, and incubated at 37 °C
with agitation during 16 h. Optical density at 600 nm
was measured at 15-min intervals using the EnSight™
Multimode Plate Reader (PerkinElmer).
Cytotoxicity assays were performed on a subset of isolates
that were selected using the following criteria: bacteraemia
duration of at least 7 days, relapse on anti-staphylococcal
treatment, vancomycin MIC increase or development of
small-colony phenotype, and possible change in toxicity
based on genetic changes (e.g. agr mutations).
Cytotoxicity was measured using a modified method
of that described previously [33, 34]. A single bacterial
colony was inoculated into 5 mL brain heart infusion
(BHI) broth (Oxoid) and incubated for 18 h at 37 °C
with agitation (180 rpm). A 1 mL aliquote was centri-
fuged (10 min, 10,000 rpm) and the supernatant col-
lected and frozen at − 20 °C. Instead of T2 cells, a
THP-1 human monocyte cell line was used. THP-1 cells
were cultured in RPMI (Lonza) supplemented with 10%
fetal calf serum, and 1% L-Glutamine (200 mM)–Penicil-
lin (10,000 units)–Streptomycin (10 mg/mL) solution
(Sigma) at 37 °C for 2 to 4 days. For testing, THP-1 cells
were centrifuged (10 min, 1200 rpm, 22 °C) and
resuspended in Dulbecco’s Phosphate Buffered Saline
(Thermo Scientific) to a concentration of 2.4–3.0 million
cells/ml. Bacterial supernatant (diluted 50% in BHI
broth) and THP-1 cells were mixed in a 1:1 ratio
(using 20 μl volumes) and incubated for 12 min at
37 °C. After incubation, 20 μl of Trypan Blue Solu-
tion (Corning) was added and 20 μl was loaded onto
a disposable cell counting slide (Immune Systems).
Three 4 × 4 grids were counted and averaged to gain
a viable- and total-cell count. Each bacterial super-
natant was tested in technical duplicate. In the case
of the paired invasive isolates (BPH3706 and
BPH3757) where a difference in cytotoxicity was de-
tected, two additional biological replicates (each tested
in technical duplicate) were performed.
Variant calling
We used Snippy to map sequence reads from the same
episode to the closest available complete genome in the
NCBI repository (strain names and accession numbers
are listed in Additional file 1: Table S1) and to the de
novo assembly of the index isolate, which was generated
using SPAdes as described above and annotated with
Prokka [35]. A consensus sequence of the references was
generated by mapping the reads of the index isolate
(using Snippy). In addition, we filtered variants called for
paired isolates by reviewing the alignment of the index
isolate reads and excluding positions, where read cover-
age was below 10 and the fraction of reads identical to
the reference was below 50%. All variants were manually
validated by comparing the read alignments of the index
isolate and the paired isolate. The filtering was per-
formed using SAMtools mpileup, version 1.4, and the
alignments were inspected using SAMtools tview, ver-
sion 1.4 [36].
To test whether masking repetitive regions might im-
prove variant calling, we used NUCmer, version 3.1 [37],
to identify repetitive regions on the closest available
complete genome and repeated the Snippy run after
masking these regions from the reference.
Episode-specific phylogenies
For two cases where multiple isolates per patient were
available, we inferred an episode-specific phylogeny.
Core-genome alignment on the closest complete genome
was “curated” by filtering SNPs as described above.
Maximum-likelihood phylogeny was inferred using
IQ-tree and tree were rooted at midpoint.
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Annotation and functional classification of mutated gene
products
The clustering tool CD-HIT, version 4.6.7 [38], was ap-
plied to compare proteins whose sequence was altered
by mutations confirmed by the approach described above.
Unique protein sequences were annotated by assigning
Clusters of Orthologous Groups (COGs) using Reverse
Position Specific BLAST (rpsblast), version 2.5.0. The COG
database was downloaded from NCBI (ftp://ftp.ncbi.nih.
gov/pub/mmdb/cdd/little_endian). Rpsblast results were
parsed using the Biopython package [39] Blast, module
NCBIXML.
Annotation and convergence analysis of intergenic regions
Mutations in intergenic regions were annotated using an
adapted Biopython script (http://biopython.org/wiki/
Intergenic_regions) and convergence among mutated
intergenic regions was explored first using CD-HIT and
then by performing an all-vs-all blastn search, as de-
scribed in the pipeline Piggy [40].
Detection of chromosome structural variants
To detect larger deletions, the episode-specific alignment
to the complete reference genome was analysed using
BEDTools, version 2.26.0 [41] to identify unique intervals
within the patient isolates (i.e. not present in all isolates
from the same patient) with at least 400 bp read coverage
loss. The 400-bp threshold was determined empirically
based on the distribution of the length of deletions using a
1000-bp window in BEDTools coverage. Insertions and
smaller deletions were identified by analysis of split reads.
Split reads (i.e. reads that cannot be represented by a lin-
ear alignment and therefore have one or more supplemen-
tary alignments as specified in the SAM format available
at https://github.com/samtools/hts-specs) were extracted
from the episode-specific alignment to the complete refer-
ence genome using a python script that is part of the
LUMPY framework (https://github.com/arq5x/lumpy-sv).
We kept split reads that were unique to one or more iso-
late per episode and had a breakpoint (defined by start or
stop of the read alignment) with a coverage > 10. Break-
points and read coverage at breakpoint were obtained by
parsing the SAMtools mpileup output. Unique split read
intervals were confirmed by manual inspection of the
alignment, and the primary interval and the supplemen-
tary intervals were annotated using the complete genome
in GFF format and BEDTools. To confirm variants identi-
fied with the split read analysis, we performed a BLAST
search for primary and supplementary intervals on the de
novo assembly graph of the isolates using Bandage, version
0.8.1 [42]. Structural variants were visualised using Gen-
eious, version 8.1.7 (Biomatters).
Pan-genome analysis
We used Roary, version 3.12.0 [43], to generate ortholog
clustering from assemblies of closely related isolates
(annotated with Prokka). To exclude genes inaccurately
attributed to the accessory genome, we mapped reads to
a multi-fasta file of the accessory genes using
BWA-MEM, version 0.7.17-r1188 [44], and scanned the
alignment with BEDTools. Only genes for which at least
one isolate had a coverage breadth of 0 and at least one
isolate had a mean coverage depth of 10 were classified
as true accessories. The relevance of the resulting
accessory genes was checked using blast to confirm that
the sequences were S. aureus.
IS256 BLAST search
To obtain the clonal distribution of IS256, we performed
a blastn search using the IS256 fasta sequence as a query
(downloaded from ISfinder https://www-is.biotoul.fr/)
and with the following parameters: minimum coverage
90%, minimum identity 95%, wordsize 32, and evalue
0.01. We searched 124 complete genomes available in
NCBI repository in May 2017 and 130 draft assemblies
of the isolates included in this study.
Statistical analyses
Statistical analyses were performed in R, version 3.4.1.
The chi-square test was used to compare proportions of
isolates with at least one mutation and proportion of
non-silent mutation among isolate groups. Differences
in number of mutations among isolate groups were
assessed using the Kruskal-Wallis test. Doubling time
and maximum grow rate were calculated by fitting
curves using local polynomial regression fitting as per-
formed by the R package cellGrowth [45]. Enrichment
analysis of functional categories among mutated gene
products was performed in R by computing the hyper-
geometric test for each category using the reference gen-
ome S. aureus TW20 as control.
Results
Population structure of paired isolates from S. aureus
bacteraemia reveals a broad genetic background
A collection of 130 S. aureus isolates from 57 patients
was assembled from two multicenter cohorts of SAB
and underwent whole genome sequencing, phylogenetic
analyses, phenotypic comparisons, and analysis for gen-
omic variants (Fig. 1a–f and Additional file 2: Figure S1).
We included 50 SAB episodes with at least two blood
isolates collected at a minimum of 3 days apart (50 index
isolates, 61 paired invasive isolates). In addition, 12 colo-
nising isolates were collected from 4 episodes already in-
cluded in the invasive group and 7 supplementary
episodes. The median sample delay between index iso-
late and paired invasive isolate was 8 days (interquartile
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range [IQR] 5–23). The clinical context of the paired inva-
sive isolate was persistent bacteraemia (n = 31), relapse on
treatment (n = 10), and relapse after treatment (n = 10).
Among colonising strains, seven were collected before or
at the same time as the index sample (median sampling
delay 13 days before index, IQR 1.5–71.5) and five were
collected afterwards (median delay 5 days, IQR 1–8).
The maximum-likelihood phylogeny of the collection
was inferred from 103,974 core genome SNPs (size of
the core genome alignment 1,977,743 bp) and is shown
in Fig. 2a. The population was dominated by CC8, which
represented 36% of isolates, followed by CC45 (14%),
CC5 (13%), CC22 (8%), and CC39 (7%). The dominant
clade was ST239, including four closely related strains
with novel ST types that are single-locus variants of
ST239. This clade accounted for 28% of the isolates.
This diverse population of S. aureus shows that the
paired isolates were selected from a broad genetic
background.
We then calculated the pairwise SNP distance and
used phylogenetic clustering to infer relatedness of
paired isolates and thus distinguish between persistent
or relapsing bacteraemia and co-infection or reinfection
with an unrelated strain (Fig. 1b). We also investigated
the genetic distance between index blood isolates and
their paired colonising isolate to identify SAB episodes
that were unrelated to the sampled colonising isolate.
Most same-patient isolates clustered together and exhib-
ited a pairwise SNP distance below 100 (Fig. 2b, c). In
this group, pairwise distances ranged between 0 and 98
and 0–25 SNPs, when using the common reference S.
aureus TW20 and the de novo assembly of the index iso-
late, respectively. Isolates from patient 37 were initially
separated by 717 SNPs when mapping to S. aureus
TW20. However, they were considered genetically re-
lated since they clustered together on the tree, both
belonged to ST93, and pairwise SNP distance when
mapping to the de novo assembly of the index isolate
was 6. Pairwise SNP distance between patient 19 isolates
was 266; however, this was due to phage recombination
(see below) and based on tree topology and MLST these
isolates were also categorised as genetically related. Nine
paired isolates (seven paired invasive and two paired
colonising) had a SNP distance to the index larger
than 10,000 bp and were also different by multilocus
sequence type (MLST). We therefore defined these
isolates as genetically unrelated to the index and ex-
cluded them from further analysis of in vivo diver-
sity. The seven unrelated paired invasive isolates
were collected after a longer interval as compared to
isolates that were genetically close to the index sam-
ple (median sampling delay 72 vs. 7 days, p = 0.002,
Fig. 3a). Thus, reinfection with a different clone as
defined by genetic unrelatedness occurred in 7 out
of 50 (14%) cases of SAB included in this study. This
is consistent with a previous publication by Fowler
et al., where 20% of SAB recurrences were reinfec-
tions, as defined by pulsed-field gel electrophoresis
(PFGE), a technique that has lower resolution than
whole-genome sequencing (WGS) [46].
After exclusion of unrelated isolates pairs, 51 episodes
with 115 isolates were retained for in-depth genomic
and phenotypic within-host diversity analysis (Fig. 1c–f ).
Paired invasive isolates have low genetic diversity
The choice of the reference genome and the filtering of
variants has an impact on the number of identified
mutations [47]. Therefore, to obtain the most accurate
estimate of within-host diversity in paired isolates, we
applied an episode-specific genome mapping approach.
By mapping sequence reads to both the closest available
complete genome from the NCBI repository and a de
novo polished assembly of the index isolate and thor-
ough review of the variants through manual inspection
of the alignments, we were able to effectively eliminate a
significant number of false-positive mutation calls and
retain only true genetic variation (Additional file 2:
Figures S2 and S3). While manual inspection has been
applied in other within-host genomic studies [5], one al-
ternative approach may be masking repetitive regions,
where mapping errors are more likely to occur, as imple-
mented in some variant calling pipelines [48]. However,
using manual inspection as the gold standard, we calculated
in our dataset that masking repetitive regions on the refer-
ence (closest available complete genome) would result in a
sensitivity and specificity of 93% and 21%, respectively.
Using this approach, we identified a total of 182 variants
(141 SNPs and 41 small indels [median size 1 bp, IQR 1–
1]) in 32 out of 64 paired isolates. We observed very lim-
ited genetic diversity in paired invasive isolates compared
to paired colonising isolates (Fig. 3b). Only 23 (43%) of 54
paired invasive isolates exhibited at least one mutation,
while 9 out of 10 paired colonising isolates were mutated
(p = 0.016). Among isolates with at least one mutation, the
median number of variants in paired invasive and paired
colonising isolates was 2 and 12, respectively (p = 0.014).
Among 158 unique variants, 81 (51%) were predicted to
result in changes in protein function: 60 were missense
substitutions, 5 were nonsense substitutions (leading to a
premature stop codon), and 16 were frameshift mutations.
The remaining 77 mutations occurred in non-coding re-
gions (47) or were synonymous substitutions (30) (Add-
itional file 3: Table S2).
Colonising isolates and late relapses have a distinctive
molecular signature
While the rate of mutation in S. aureus may be dependent
on the genetic background [49], it is unknown whether
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evolution rates are different during invasive infection,
where host immune response and antibiotic treatment
exert a strong selective pressure. We therefore explored
associations between mutation counts and clinical, pheno-
typic, and genetic characteristics of the paired isolates. No
association was found between mutation count and
MRSA status or clonal complex. Interestingly, while there
was a weak correlation between length of the collection
interval of invasive isolates and mutation count (Fig. 3b),
the association was not linear, with an increase in
~5000 SNPs
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Fig. 2 a Maximum-likelihood tree of 130 isolates from 57 patients with Staphylococcus aureus bacteraemia, rooted using Staphylococcus argenteus
as outgroup. Patient-specific shape-colour combinations annotate branch tips. White circles indicate nodes with ≥ 95% ultrafast support and ≥
80% SH-like approximate likelihood ratio test support. Frequency distribution of pairwise single-nucleotide polymorphism (SNP) distance between
isolates from the same patient using the common reference S. aureus TW20 (b) and the de novo assembly of the index isolate (c)
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mutation counts when the collection interval exceeded
15 days (Additional file 2: Figure S4). Since 15 days is the
usual duration of treatment of uncomplicated SAB [50],
this suggests that genetic diversity was higher when the
paired isolate was collected after treatment. Consistent
with this observation, we found a significantly higher
number of mutations in paired invasive isolates from re-
lapses after completion of anti-staphylococcal treatment
(median 4.5 mutations per isolate) as compared to isolates
from persistent bacteraemia or relapses on treatment (me-
dian 0 mutations) (Fig. 3c). In terms of genetic diversity,
isolates from relapses after treatment were as genetically
diverse as paired colonising isolates compared to index
isolates (Fig. 3c), indicating that they might represent re-
infection with a closely related strain (in other words, a
new invasive event from the colonising compartment) ra-
ther than the result of a persistent invasive focus.
Episode-specific phylogenies for two patients for whom
multiple isolates were available (patients 27 and 38) con-
firm this pattern (Additional file 2: Figure S5).
A similar pattern was discovered when we analysed
the predicted mutation effects on the encoded proteins.
The proportion of non-silent mutations (either nonsy-
nonymous or stop-gained or frameshift) decreased
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progressively from 72% in invasive isolates from persist-
ent bacteraemia or relapse on treatment to 63% in iso-
lates from relapse after treatment to 43% in colonising
isolates (Fig. 3d). The high proportion of non-silent mu-
tations (66% vs. 43%, p = 0.002) indicates that the inva-
sive compartment may be under stronger positive
selection compared to the “colonising compartment”.
On the other hand, mutations found in late relapses
might arise in the colonising compartment rather than
during invasive infection.
Adaptation pathways are episode-specific
To identify possible convergence of mutation pathways
among the 82 variants associated with predicted change
in protein sequences, we applied protein sequences
clustering using CD-HIT (Additional file 4: Table S3).
Overall, mutation pathways were highly diverse and
episode-specific. The only protein-coding gene that was
mutated in more than one episode was the accessory
gene regulator component agrA, with a nonsynonymous
SNP in a paired invasive isolate (T88M) and a frameshift
in a colonising isolate (at position 127). No convergence
was observed among mutations arising in intergenic
regions.
Given the weak convergence among mutated genes, we
attempted to identify common pathways of within-host di-
versity by categorising the mutated proteins using the
Clusters of Orhologous Groups (COG) database and per-
forming an enrichment analysis using reference genome S.
aureus TW20 as a comparator. Analysis of 17 categories
did not show any significant enrichment. Nevertheless,
genes related to cell wall and membrane biogenesis among
paired invasive isolates reached the lowest p value (uncor-
rected p value 0.063, Additional file 2: Figure S6). Overall,
different pathways were affected by mutations in invasive
and colonising pairs, an observation that is consistent with
distinctive selective pressures in the nasal and the blood
compartment.
Mutations in pairs with observed phenotypic changes
Antibiotic resistance and growth rate
Within-host phenotypic adaptation might indicate diver-
sifying selection under the selective pressure of antibi-
otics and the immune system [51]. Therefore, we
identified pairs with changes in specific phenotypes be-
tween the index isolate and paired isolates. We selected
invasive pairs, as they were associated with a stronger
positive selection signature with a higher proportion of
non-silent mutations. We performed a pairwise analysis
of phenotypes related to commonly used antibiotics for
treating invasive S. aureus infections that may have
changed in response to selective pressure (vancomycin
MIC and oxacillin MIC, growth rate) (Additional file 2:
Figure S7). Significant changes in phenotypes were ob-
served in a small number of episodes (increase in vanco-
mycin MIC of ≥ 1 μg/ml, 3 episodes, sharp decrease in
growth rate leading to small colony variants [SCV], 3 ep-
isodes). Details of these episodes are shown in Table 1.
Genetic changes underlying the SCV phenotype and
secondary increase in vancomycin MIC were diverse, in-
dicating that phenotypic convergence was not associated
with genetic convergence (Table 2). Patient 3 presented
with a ST45-MRSA bacteraemia, which was associated
with a dialysis-catheter device and was treated with
vancomycin for 14 days. She had recurrent bacteraemia
38 days after the first episode. The recurrent strain exhib-
ited an increase in vancomycin MIC from 0.75 to 2 μg/ml
and a SCV phenotype. We identified four mutations aris-
ing in the relapsing strain: a non-synonymous SNP in the
rpoB gene leading to an arginine-histidin substitution in
position 503 (R503H), a deletion in position 283 of the
rplV gene (ribosomal protein 22), a deletion in position 66
of the rplD gene (ribosomal protein 4), and a deletion
leading to a truncation of gene ptsG. The rpoB R503H and
ribosomal protein mutations have been previously
described in in vitro selected vancomycin-intermediate
mutants [52, 53], but never in clinical isolates. The rpoB
R503H mutation is not associated with rifampicin
resistance, consistent with the lack of exposure to rifampi-
cin in this case. Patient 5 was treated with vancomycin for
3 days and flucloxacillin for 13 days for a ST15-MSSA
catheter-related bacteraemia and experienced relapse at
day 18. The relapsing strain had a SCV phenotype and
vancomycin MIC increased from 1.5 to 2 μg/ml. It had a
nonsynonymous SNP in the serine/threonine phosphatase
(stp) gene leading to a N137D mutation. stp mutations
have been identified previously in persistent SAB with
secondary development of vancomycin-intermediate S.
aureus (VISA) [54, 55]. Finally, patient 30 had relapsing
ST5-MRSA bacteraemia after 14 days of vancomycin
(combined with rifampicin and ciprofloxacin). Median
doubling time of the relapsing strain increased from 42 to
83 min, while vancomycin MIC increased from 1.5 to 2 μg/
ml. Mutation analysis identified a deletion in a protein
whose function could not be predicted and a
non-synonymous SNP (mutation A60D) in the ywlC gene,
which encodes a translational factor (threonylcarbamoy-
l-AMP synthase) [56]. This gene has never been linked to
vancomycin resistance or growth rate. However, a ywlC
ortholog has been shown to be essential in E. coli [56]; thus,
it is possible that point mutations impair S. aureus growth.
In two episodes with an increase in vancomycin
MIC by at least 1 μg/ml, no mutation separated the
index isolate from the paired isolate, suggesting that
other genetic changes may have occurred (see
below).
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Cytotoxicity
Recently, it has been shown that within-host evolution
from colonising to invasive S. aureus can be associated
with a dramatic decrease in cytotoxicity [57]; however, it is
unknown whether a similar trend can be observed during
persistent infection. To assess evolution of cytotoxicity
during SAB, we tested a subset of 21 episodes that were
considered more likely to be associated with changes
based on phenotypic characteristics (i.e. longer dur-
ation of bacteraemia, relapse on anti-staphylococcal
treatment, small colony phenotype or secondary in-
crease in vancomycin MIC) or because of mutations
in the agrA gene.
Similar to the other pairwise phenotypic tests, cytotox-
icity remained unchanged between index isolate and
paired isolate, with the dramatic exception of one paired
invasive isolate with agrA mutation T88M, which was
associated with a marked reduction in THP-1 cell lysis
(from 56% non-viable cells to 11%) as compared to the
index isolate (Additional file 2: Figure S7).
Table 1 Summary of episodes with phenotypic changes
Patient code Type of
isolate
Collection
interval (days)
Context of
paired isolate
Days of
treatment
Principal
antibiotic
mecA Van MIC
(μg/ml)
Median doubling
time
Mutations
(SNP/indels)
Non-silent
mutations
Small-colony variant and vancomycin MIC increase
P_03 Index – – – – Pos 0.75 34.5 – 0
P_03 Paired
invasive
38 Relapse (after treatment) 14 Van Pos 2 53.9 4 (1/3) 4
P_05 Index – – – – Neg 1.5 38.4 – 0
P_05 Paired
invasive
18 Relapse (after treatment) 12 Flx Neg 2 50.6 1 (1/0) 1
P_30 Index – – – – Pos 1.5 42.1 – 0
P_30 Paired
invasive
14 Persistent 14 Van Pos 2 83.5 2 (1/1) 2
Vancomycin MIC increase
P_42 Index – – – – Pos 2 44.7 – 0
P_42 Paired
invasive
9 Persistent 8 Van Pos 3 46.5 0 (0/0) 0
P_46 Index – – – – Pos 2 50.6 – 0
P_46 Paired
invasive
23 Relapse (on treatment) 21 Van Pos 3 48.9 0 (0/0) 0
Van vancomycin, Flx flucloxacillin, MIC minimum inhibitory concentration, SNP single nucleotide polymorphism
Table 2 Mutations in episodes with phenotypic changes
Patient
code
Gene Type Mutation Product Category Significance
P_03 ptsG del G306fs (stop at
residue 341/682)
PTS system glucose-
specific EIICBA
component
Carbohydrate transport
and metabolism
Three-component glucose transporter with
phosphorylation activity [73]. ptsG deletion
associated to resistance to glycosylated
bacteriocins [74]
P_03 rpoB snp R503H DNA-directed RNA
polymerase subunit
beta
Transcription R503H associated with VISA phenotype in vitro.
No rifampicin resistance [52]
P_03 rplV complex AIN95GR 50S ribosomal protein
L22
Translation, ribosomal
structure and biogenesis
Association with slow growth in in vitro selected
VISA harbouring rpoB A621E [53]
P_03 rplD del KG68del 50S ribosomal protein
L4
Translation, ribosomal
structure and biogenesis
Mutations at positions 68 and 69 associated
with linezolid resistance [75] and macrolide
resistance [76]
P_05 stp snp N137D Serine/threonine
phosphatase stp
Signal transduction
mechanisms
VISA phenotype in clinical strains; confirmed by
mutagenesis [54, 55]
P_30 – del HVC139R hypothetical protein Function unknown
P_30 ywlC snp A60D Threonylcarbamoyl-AMP
synthase
Translation, ribosomal
structure and biogenesis
Required for the attachment of a threonylcarbamoyl
group to ANN-decoding tRNA [56]
PTS phosphotransferase system, VISA vancomycin-intermediate Staphylococcus aureus, AMP adenosine monophosphate
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Chromosome structural variants
The potential significance of chromosome structural var-
iants in S. aureus resistance and adaptation has been re-
cently highlighted [13, 58]. However, when using only
partially assembled genomes or read-mapping, the char-
acterisation of structural variants is much more challen-
ging than SNP calling and these types of changes are
often overlooked. Using an approach combining read
coverage arithmetic, read filtering, and annotation of
split reads (Fig. 1e, f ), we detected 21 unique structural
variants within 15 SAB episodes: two plasmid losses, five
large deletions (ranging from 261 to 15,622 bp), one re-
combination, and 13 insertions (summarised in Table 3).
Beside the two instances of plasmid loss, which may
have occurred after isolate collection/storage, two large
structural changes were particularly interesting. A re-
combination of prophage Sa phi3 encoding the immune
escape cluster (IEC) was identified when comparing the
index blood isolate of patient 19 with its paired colonis-
ing isolate, based on accumulation of 192 mutations and
discovery of a 6643-bp deletion on the index isolate. As
a consequence, the invasive isolate carried the staphylo-
kinase gene (sak) and the staphylococcal complement in-
hibitor gene (scn), while the colonising isolate carried
the complete IEC including sak, scn, and the chemotaxis
inhibitory protein (chp). Since there were no enterotoxin
genes, this constellation can be classified as IEC types E
and B, respectively, according to the classification pro-
posed by van Wamel et al. [59]. In patient 21, we ob-
served a deletion of pathogenicity island SaPi2 in the
paired invasive isolate that was collected upon relapse of
bacteraemia 65 days after the first episode. To complement
the exploration of chromosome structural variants, we per-
formed a pan-genome analysis, which confirmed major
changes already identified (two plasmid losses, phage re-
combination, and SaPi2 deletion) and allowed us to identify
a previously undetected loss of an ICE6013 element.
The most prevalent structural change in our cohort
was the insertion of IS256 elements. We observed 13
unique IS256 insertions in 8 episodes. Interestingly, the
number of insertions did not correlate with the number
of mutations, and up to three new IS256 insertions were
found in paired invasive isolates with no mutations rela-
tive to index (Additional file 2: Figure S8).
Intriguingly, all strains with new insertions belonged
to ST239 or to a closely related single-locus variant of
ST239. A BLAST search of the 1324-bp-long IS256 se-
quence among all available S. aureus complete genomes
and the draft assemblies of the 130 isolates included in
our study confirmed that IS256 is highly disseminated in
ST239 and restricted to a few other sequence types
(Additional file 2: Figure S9).
We mapped split reads that were unique within single
episodes on a single ST239 reference genome (S. aureus
TW20) and found that there were hotspots for these
new IS256 insertions on the chromosome (Fig. 4). One
of these hotspots was the genomic island niSa beta with
unique new insertions in four different patients, two of
them around the lantibiotics operon. Moreover, we dis-
covered that the paired invasive isolate from patient 46
had three new IS256 insertions including one 150 bp up-
stream of the walKR operon. This finding was relevant
because the isolate showed an increase in vancomycin
MIC from 2 to 3 μg/ml as compared to the index iso-
late but no point mutations were found (see above).
Notably, IS256 insertion and tempering of WalKR ac-
tivity has been previously shown to cause VISA pheno-
type in vitro but has never been described during
human infection [58].
Discussion
This large-scale comparative genomics study of patients
with persistent or recurrent SAB provides the first com-
prehensive overview of within-host S. aureus diversity
associated with bacteraemia. By compiling a curated in-
ventory of mutational and structural within-host variants
across different genetic backgrounds and manifestations
of SAB, we show that invasive isolate pairs have a spe-
cific molecular signature (denoted by limited diversity
and a high proportion of non-silent mutations) and that
structural variation and especially insertion of IS256 ele-
ments enhances genetic diversity during human infec-
tion. With the notable exception of agrA, which was
mutated in one invasive pair and one invasive-colonising
pair, there was no convergence at the gene level among
mutations and indels, indicating that pathways of adap-
tion are episode-specific, even when we found common
phenotypic changes within pairs. Loss of agr function
within the host has been previously described both
among colonising isolates [5] and during invasive infec-
tion [8, 60]. Enrichment for agrA mutations was also ob-
served in a study of 105 colonising-invasive pairs [7].
While one of the two mutations was associated with the
only significant reduction in cytotoxicity observed in our
cohort, none led to an increase in vancomycin MIC, des-
pite the known link between agr dysfunction and vanco-
mycin resistance [61].
When considering bacterial within-host diversity in in-
vasive S. aureus infections, it is important to keep a
“pathogen-centric” perspective and consider a model
consisting of two “compartments”, i.e. the colonising
compartment (anterior nares, or other mucosal areas)
and the invasive compartment (blood and tissue/organs
of primary or metastatic S. aureus infection). Bacteria in
the colonising compartment are subjected to evolution
pressures (competition of the nasal microbiota, some
immune system control and intermittent antibiotic
exposure at low concentration) but also to purifying
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selection, since colonisation sites such as the nose are
the natural ecological niche of S. aureus [51, 62]. By con-
trast, bacterial invading blood and tissue are subjected to
a formidable selective pressure, including antibiotics at
high concentration, host antimicrobial peptides, immune
cells, and sequestration of nutrients (e.g. iron). This is sup-
ported by convergent evolution analysis at the gene ontol-
ogy level. In this study, a non-significant enrichment for
mutations in genes associated with cell wall and mem-
brane metabolism was found in paired invasive isolates,
while enrichment for genes associated with cell wall and
adhesion was described by Young et al. among colonising-
invasive pairs [7].
Since the advent of WGS, studies addressing within-
host diversity of S. aureus bacteraemia have mainly
focused on genetic changes associated with secondary
development of the VISA phenotype under vancomycin
pressure [8, 9, 11, 13, 54, 63], or with secondary develop-
ment of daptomycin resistance [10]. By selecting SAB epi-
sodes with phenotypic changes, this approach helps to
distinguish evolution in the blood/tissue compartment
from background diversity of the colonising S. aureus
Table 3 Overview of chromosome structural variants
Patient
code
Type of variant Reference (position) Annotation Isolate with variant
P_27 Plasmid loss S. aureus TW20 29,585 bp-plasmid containing the
chlorhexidine tolerance determinant
qacA and cadmium resistance genes
Index, paired invasive, one paired
colonising (second paired colonising
like reference)
P_30 Plasmid loss S. aureus SA564 27,272 bp-plasmid containing the beta-
lactamase operon
Index (paired invasive like reference)
P_05 Deletion S. aureus NCTC_8325
(2188042)
861 bp-deletion (fructose bisphosphate
aldolase)
Paired invasive
P_12 Deletion S. aureus NCTC_8325
(1502725)
261 bp-deletion (phage protein) Index (paired invasive like reference)
P_14 Deletion S. aureus FORC_001
(1953000)
597 bp-deletion (hypothetical protein) Paired invasive
P_21 Deletion S. aureus SA564 (798999) 15,622 bp deletion of pathogenicity
island SaPi2
Paired invasive
P_54 Deletion S. aureus AUS0325 (1191813) 495 bp-deletion (serine/threonine-protein
phosphatase)
Index (paired colonising like reference)
P_19 Recombination S. aureus CA-347 (1577530) Phage Sa phi3 recombination Index (paired colonising like reference)
P_22 Insertion S. aureus TW20 (2243085) IS256 insertion (prophage phiSPbeta-like) Paired invasive
P_27 Insertion S. aureus TW20 (173671) IS256 insertion (putative DNA-binding
protein)
Index and one paired invasive
P_27 Insertion S. aureus TW20 (1223135) IS256 (putative membrane protein) Index, paired invasive (paired colonising
like reference)
P_27 Insertion S. aureus TW20 (1971406) IS256 insertion (lantibiotic immunity protein,
genomic island niSa beta)
Index, paired invasive, one paired
colonising (second paired colonising like
reference)
P_27 Insertion S. aureus TW20 (173,671,
173,626)
IS256 insertion (putative DNA-binding
protein)
Index and one paired invasive
P_34 Insertion S. aureus TW20 (1619645) IS256 insertion (hypothetical protein) Index (paired invasive like reference)
P_39 Insertion S. aureus TW20 (1955676) IS256 insertion (genomic island niSa beta) Index (paired invasive like reference)
P_46 Insertion S. aureus TW20 (24644) IS256 insertion (upstream of walKR operon) Paired invasive
P_46 Insertion S. aureus TW20 (528848) IS256 insertion (exotoxin, genomic island
niSa alpha)
Paired invasive
P_46 Insertion S. aureus TW20 (2306594) IS256 insertion (phage protein) Paired invasive
P_47 Insertion S. aureus str._JKD6008
(1914213)
IS256 insertion (genomic island niSa beta) Paired invasive
P_47 Insertion S. aureus str._JKD6008
(2227509)
IS256 insertion (P-ATPase superfamily P-type
ATPase potassium (K+) transporter subunit A)
Paired invasive
P_49 Insertion S. aureus str._JKD6008
(702665)
IS256 insertion (upstream of sodium/hydrogen
exchanger family protein)
Paired invasive
P_52 Insertion S. aureus TW20 (1955675) IS256 insertion (genomic island niSa beta) Paired colonising
Bp base pair
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population. Our study complements this previous work by
providing for the first time a wider picture of within-host
diversity in SAB in a diverse genetic background. By using
phenotypic tests such as vancomycin susceptibility testing
and growth curves, we showed that secondary changes
were present in a small proportion of cases. However,
even in this group with more evident features of positive
evolution, we found a heterogeneity of mutations. This
observation, together with the wide range of alleles
described in the VISA literature [61], highlights the
multiplicity of pathways by which S. aureus adapts to
vancomycin pressure in vivo. Mutations identified in
episodes without detected phenotypic changes were
also very heterogenous, and thus we were not able to
detect convergence in our dataset or identify muta-
tional hotspots that were associated with persistence
or recurrence. This clearly shows that we should be
careful in drawing general conclusions on S. aureus
pathoadaptation from mutations identified in single
clinical cases.
One striking finding was the combination of limited
genetic variability and high frequency of non-silent
mutations among invasive pairs. This is consistent
with the “bottle neck” hypothesis of SAB, as shown in
animal models, where only individual clones among
the diverse colonising pool become invasive [64]. Des-
pite the lack of identified molecular hotspots of per-
sistence, this signature (low abundance of mutations
and low fraction of “silent mutations”) may help dis-
tinguish between reinfection with a close related colo-
nising strain from relapse from a persistent infection
focus. On the background of increased availability of
WGS, within-host diversity data could be used not
only to understand the pathogenesis of SAB and anti-
biotic resistance, but also to inform clinical manage-
ment of persistence or recurrence.
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Mobile genetic elements (MGE) are key drivers of
evolution in S. aureus [65]. Evolution experiments in
vivo have shown an intense exchange of MGE in
piglets co-colonised with different lineages of S. aur-
eus [66], and there is evidence of phage recombin-
ation in studies of same-patient colonising isolates
[5, 62]. In addition to MGE, we have recently illus-
trated that a large chromosome duplication mediated
vancomycin resistance and immune evasion in a case
of extremely protracted SAB [13]. However, we do
not have an overview of structural variation and
MGE movements during clinical invasive S. aureus
infection. Therefore, we applied an episode-specific
strategy to detect structural variation by carefully
assessing read coverage and split reads within the
pairs to identify unique structural changes that were
confirmed by review of the assembly graphs. This
mapping-based approach allowed us to reveal large
changes occurring even in the absence of point mu-
tations. Some of these modifications may have a
relevant impact on the phenotype. For example, we
observed the loss of pathogenicity island SaPI2 in a
paired invasive isolate and a recombination of phage
Sa phi3 (including the IEC) in an invasive-colonising
pair.
While deletion and recombination were episode-
specific without a discernible pattern, a striking find-
ing was the remarkable high frequency of new IS256
insertions within the same episode among strains be-
longing to the dominant lineage ST239 (at least one
insertion event in 8 out of 13 episodes) with the gen-
omic island niSa beta as a hotspot of new insertions.
This genomic island is enriched with IS256 that has
been shown to engender chromosomal inversion in
an ST8-IV MRSA [67]. The effect of the new IS256
insertions in genomic island niSa beta in our paired
clinical isolates are uncertain, although insertions
around the lantibiotic operon could be important in
modulating the production of lantibiotics depending
on whether S. aureus is in the colonising compart-
ment (i.e. competing with other microbiota) or is in-
vasive [68]. Up to three new insertions occurred in
paired isolates even in the absence of point muta-
tions, suggesting that IS256 is an efficient mechanism
of genetic variability in the environment of invasive S.
aureus infection, characterised by high selective pres-
sure and reduced effective population size, as it is
known that bacterial stress like antibiotic exposure
activates insertion sequences [69, 70]. A paradigmatic
example was the insertion of IS256 upstream of the
walKR operon (in an isolate whose vancomycin MIC
increased from 2 to 3 μg/ml), a mechanism that we
and others have previously elucidated in in vitro
selected VISA strains [58, 71]. Based on these latter
studies and others [72] showing that IS256 is selected
for in vitro, we hypothesise that the new insertions
were mediated by a “copy-paste” mechanism rather
than transfer from an external donor (within the
colonising compartment); however, short-read data do
not allow to assess IS256 diversity within the same
genome.
Our study has some limitations. Because patients were
recruited at detection of positive blood cultures for S.
aureus, colonising S. aureus strains were available only
for a very small proportion of patients. Therefore, we in-
cluded invasive-colonising pairs as a comparator to inva-
sive pairs, but our dataset prevents conclusions on
molecular signatures on “invasiveness” of S. aureus. Fur-
thermore, in our study, one colony per sample was se-
quenced. Recent work has exposed the diversity of
colonising and invasive S. aureus strains by sequencing
multiple colonies per sample (up to 12) [5, 6]. Data ob-
tained from this “high resolution” approach can then be
used to better infer within-host phylogenies and shed
light into the pathogenesis of SAB. Because of this limi-
tation and the fact that for most episodes only one add-
itional invasive isolate was available, care should be
taken in driving conclusions on within-host evolution
during SAB, since the genetic changes we observed
may only represent inherent diversity rather than an
evolutionary process. Additionally, we tested only a
limited array of phenotypes. Data on more complex
phenotypes (e.g. immune evasion) might have furn-
ished additional insights into the impact of the host
immunity on S. aureus evolution within the blood or
tissue compartment. Finally, since our analysis of
structural variants is based on short read data, we
may have missed structural changes that can be usu-
ally only detected by long-read sequencing, such as
chromosomal inversion.
Conclusions
By applying comparative genomics to 57 episodes of
SAB with sequential invasive S. aureus isolates or paired
colonising isolates, we describe specific patterns of S.
aureus diversity within the invasive compartment (in
particular limited within-host diversity and strong posi-
tive selection signatures), that might be indicative of the
adaptive changes under the combined pressure of antibi-
otics and host immunity. Furthermore, we highlight the
crucial role of structural changes and in particular MGEs
like insertion sequences in conferring genetic plasticity
within the host. Data from this study will improve our
understanding of the bacterial pathogenesis of SAB and
contribute to defining a molecular signature of persist-
ence/relapse that might be used for both biological re-
search and infection management.
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